key: cord-0857439-6sxi2j6r
authors: Pritchett, Joshua C.; Haddad, Tufia C.
title: Avoiding the “Faux Equalizer”
date: 2021-10-30
journal: Mayo Clin Proc
DOI: 10.1016/j.mayocp.2021.08.010
sha: 109e3bac744bdb47f1390df36a25ff43f042d439
doc_id: 857439
cord_uid: 6sxi2j6r

nan

Avoiding the "Faux Equalizer" Joshua C. Pritchett, MD, and Tufia C. Haddad, MD I n the early days of the coronavirus disease 2019 (COVID-19) pandemic, health care institutions around the world were upended. In adapting to meet the unprecedented needs of the moment for our patients, this force of necessity conjured an extraordinary and irreversible evolution in the delivery of patient care, signified perhaps most strikingly by the robust expansion of virtual health care.

Burgeoning technologies such as telemedicine, remote patient monitoring (RPM), and hospital-at-home solutions promise to not only transform but enhance the care that we deliver. They also offer a potential bridge to serving patient populations that have long suffered from systemic disparities in access to health care. However, the COVID-19 pandemic has taught us that these technological bridges, if not conscientiously built, appear poised to widen the chasm.

In 2016, the CEO of Google made the following statement: "I've always been fascinated by this thing, that every jump in technology involves leveling the playing field."

In response to this notion, The Atlantic ran a piece 1 describing technological advancement as a "faux equalizer," with the unapologetic subheading: "Silicon Valley's sunny outlook on technology and opportunity ignores systematic inequalities."

In health care, the time it takes to "level the playing field" will be measured in our patients' lives, health, and well-being. If "faux equalization" comes to our industry, this will be the cost; and the price will be steepest in communities that are already our most vulnerable and marginalized. A wave of transformative technologies, galvanized by the COVID-19 pandemic, is poised to shape the future of our industry for years to come. What remains less certain is whether health care systems and innovators will be abledand willingdto avoid the consequences of "faux equalization" that have characterized the dawn of most major technological advancements since the industrial revolution. 1 To be effective advocates for our patients, we must learn this history. We must be willing to acknowledge and confront our long-standing systematic and structural disparities. If we are to avoid the steep costs of the status quo, health care innovation must be born from a posture of openness and active engagement with the communities we seek to serve. And we must demand these same priorities of our industry partners at the genesis of technology development.

In this spirit, we share the following experience from our journey of telehealth and virtual care innovation during the COVID-19 pandemic. Reflecting on this experience has helped reinforce our team's commitment to understanding the perspectives and priorities of our diverse communities as we seek to build technologies that extend and deliver health care to all people.

In March 2020, we implemented an RPM program for patients diagnosed with COVID-19 who were at risk for severe illness. 2 From the outset, the program was designed to be patient centered and widely accessible; specifically, exclusion criteria were removed from our previously established chronic condition RPM program, so patients with COVID-19 who were pregnant, non-English speaking, or recipients of a transplant or active cancer treatment could all benefit from the program. In anticipation of potential barriers in access to technology, cellular-enabled tablets and medical devices were provided to all patients upon enrollment. There was also no insurance coverage requirement for program participation. Through this program, our institution was able to provide effective and dynamic monitoring for more than 10,000 patients across our campuses while decreasing risks of exposure and transmission associated with conventional care. [3] [4] [5] [6] By April, however, as disease outbreaks emerged at meatpacking facilities in the Midwest, 7 disparities in program adoption became an increasing concern. We observed that Hispanic/Latinx patients, some with limited English language proficiency, were declining RPM enrollment more frequently than other populations. To immediately address language barriers, we bolstered our Spanish language medical interpreter services. Then, as it became clear our technology partner could not support full Spanish language integration, we transitioned to a new platform with this capability. Despite these programmatic changes, low adoption rates persisted and proved that the roots of the problem ran deeper.

Through engagement with community leaders, our team was provided with evidence of deep cultural mistrust that extended far beyond language barriers. Specifically, many of these patients feared being "tracked" by the RPM technologyda direct result of heightened local and national antiimmigrant tensions and rhetoric. With these new insights, we developed specific scripting for our team members to build trust and allay fears throughout the patient welcome and onboarding process.

Unfortunately, in the time it took to identify these barriers and implement necessary changes, cases continued to soar. All told, hundreds of vulnerable patients went without monitoring. Additionally, our RPM platform was still unable to comprehensively support the primary language for hundreds of monitored patients who did not speak English or Spanish.

Our experience reinforces the duty of health care systems to promote a culture of ongoing reflection and analysis as these technologies are designed and implemented more broadly within our clinical practices and patients' homes. It also serves as a stark reminder that we cannot achieve equitable virtual care expansion without the collaboration of our industry partners.

Before the COVID-19 pandemic, utilization of virtual care was already known to be limited according to factors such as age, race, ethnicity, language, and socioeconomic status. Utilization of digital health technology by seniors, for example, was known to be significantly lower in Black and Hispanic/Latinx seniors than in White seniors, even when adjusting for educational attainment. 8 Although minority populations were already known to be particularly disadvantaged along this "digital divide," the recent study by Weber et al, 9 conducted during the peak pandemic period in New York City, has confirmed the long-feared consequences of this division. In the study, Black and Hispanic/Latinx people, regardless of age, were significantly more likely to bypass virtual care options and seek in-person care than their peers despite the clear hazards and limitations of seeking in-person care under such circumstances.

The reasons for these disparities are multifactorial, ultimately rooted in a legacy of persistent structural racism within the modern US health care system and our communities at large. 8 In view of the deeply rooted systemic barriers at play, ensuring that everyone benefits from technological advances in medicine and medical care may be challenging but is absolutely essential. In this regard, and if we hope to avoid the consequences of "faux equalization" for our patients, now is the time to identify critical areas in need of simultaneous advancement. First, we must demand that our technology partners share these priorities. Devices, algorithms, platforms, and user interfaces must be designed with diverse representation to enable equitable application and utilization. Second, as telehealth and virtual care adoption expands, securing reimbursement for high-quality evidence-based services will be essential to enable equitable access and engagement. To this end, we call on all health care systems to evaluate and share their own experiences, aimed at fostering a culture of peer-reviewed research that can be used to inform sustainable data-driven policymaking. Finally, given the cultural barriers and biases that remain pervasive within our health care systems and communities, we must commit to building trust through investment in

Technology, the faux equalizer

A scalable framework for telehealth: the Mayo Clinic Center for Connected Care response to the COVID-19 pandemic

Outcomes of COVID-19 with the Mayo Clinic model of care and research

Association of a remote patient monitoring (RPM) program with reduced hospitalizations in cancer patients with COVID-19

Managing patients in the COVID-19 pandemic: a virtual multidisciplinary approach

Implementation of a multisite, interdisciplinary remote patient monitoring program for ambulatory management of patients with COVID-19

Mapping Covid-19 outbreaks in the food system. Food and Environment Reporting Network website

Differences in access to and preferences for using patient portals and other eHealth technologies based on race, ethnicity, and age: a database and survey study of seniors in a large health plan

Characteristics of telehealth users in NYC for COVID-related care during the coronavirus pandemic